Newsroom

Sorted by: Latest

-

SADA元幹部のルシネ・イェギアザリャン、PicsartのCFOに就任しAIネイティブな動画を軸とする成長戦略を推進

マイアミ--(BUSINESS WIRE)--(ビジネスワイヤ) -- Picsartは、世界中の1億以上のクリエイターと企業がコンテンツの制作、マーケティング、収益化を行うAIを活用したメディア制作・配信プラットフォームで、ルシネ・イェギアザリャンを最高財務責任者(CFO)に任命したと発表しました。 イェギアザリャンは、Picsartが業界をリードするクリエイティブ・プラットフォームとしての従来の枠を超え、動画ファーストでAIを活用した制作エコシステムの構築へと事業を拡大する重要な局面で、同社に加わります。この取り組みはすでに進んでおり、AI機能の提供開始以来、PicsartユーザーがAIを使って作成した動画・画像は11億点を超え、年初来のAI利用は前年同期比270%増となっています。これは、急成長するAIコンテンツ市場でのシェア拡大に向けた同社の取り組みが加速していることを示しています。1 最高財務責任者(CFO)として、イェギアザリャンはグローバルな財務戦略を統括し、事業拡大と長期的な成長を推進します。就任後の最優先課題は、財務規律と、AIを軸とした事業拡大に必要なイノベーショ...
-

انضمام Lusine Yeghiazaryan، المديرة التنفيذية السابقة في SADA، إلى Picsart بمنصب المديرة المالية لقيادة استراتيجية نمو الفيديو القائم على الذكاء الاصطناعي

ميامي--(BUSINESS WIRE)--اليوم، أعلنت Picsart، منصة إنتاج الوسائط المدعومة بالذكاء الاصطناعي وتوزيعها، والتي تضم أكثر من 100 مليون من المبدعين والشركات حول العالم، عن تعيين السيدة Lusine Yeghiazaryan في منصب المدير المالي.يتناول هذا البيان الصحفي الوسائط المتعددة. يمكنك الاطلاع على البيان كاملاً هنا: https://www.businesswire.com/news/home/20260903910923/ar/Picsart, the AI media production and distribution platform, where 100M+ creators and businesses worldwide make, market and monetize content, t...
-

ETCAMAH® (camizestrant) in combination with a CDK4/6 inhibitor approved in the US for 1st-line advanced HR-positive breast cancer

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s ETCAMAH® (camizestrant) in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test...
-

ErieView Development Closes $218 Million in Financing for W Cleveland at Erieview Tower

CLEVELAND--(BUSINESS WIRE)--ErieView Development today announced the closing of financing for the $218 million conversion of Erieview Tower — turning the 40-story 1964 landmark at East Ninth Street and St. Clair Avenue into the 210-key W Cleveland hotel, expected to be the first W Hotel in Ohio, and 215 W Apartments offered for rent rather than for sale, a first for the brand worldwide. The hotel and residences are scheduled to open around late 2027. The amenity program is the most extensive as...
-

Ameribrands Acquires Randal Retail Group, Expanding National Design, Manufacturing and Installation Capabilities

BALL GROUND, Ga.--(BUSINESS WIRE)--Ameribrands, a diversified platform of specialized businesses serving the restaurant, retail, hospitality, entertainment, education and facilities sectors, recently announced the acquisition of Randal Retail Group, a leading provider of retail design, fixture manufacturing, merchandising displays and installation services. The acquisition significantly strengthens Ameribrands’ retail capabilities and advances its strategy of building a premier national platfor...
-

Eirion Risk Underwriters Launches New Inland Marine Program

ROSWELL, Ga.--(BUSINESS WIRE)--Eirion Risk Underwriters launches an Inland Marine program: broad appetite, up to $25M capacity, and direct underwriter access....
-

Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx as a companion diagnostic (CDx) to identify patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer harboring tumors with ESR1 mutations before radiographic progression who may benefit from treatment with ETCAMAH™ (camizestrant), AstraZeneca’s next-gener...
-

Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Acadia Healthcare Company, Inc. (NasdaqGS: ACHC).On September 27, 2024, the Company disclosed the receipt of a voluntary request for information from the U. S. Attorney’s Office for the Southern District of New York as well as a grand jury subpoena from the United States District Court...
-

PLNT Investors Should Contact Robbins LLP Before the September 14, 2026, Lead Plaintiff Deadline in the Planet Fitness, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Planet Fitness, Inc. (NYSE: PLNT) common stock between November 6, 2025 and May 5, 2026, inclusive (the "Class Period"). The lawsuit alleges that Planet Fitness made materially false or misleading statements regarding its membership growth, marketing strategy, pricing initiatives, and long-term financial outlook. Inves...
-

SMPL Investors Have Rights – If you Lost Money Investing in The Simply Good Foods Company Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all purchasers of The Simply Good Foods Company (NASDAQ: SMPL) common stock between October 24, 2024 and April 8, 2026 (the "Class Period"). Good Foods sells consumer packaged foods and snacking products under its various brands. The complaint alleges that Good Foods misled investors regarding the successful integration of OWYN. Investors who suffered significant loss...